Celiac disease

Celiac Disease, also known as celiac sprue or gluten-sensitive enteropathy, causes damage to the small intestine in response to gluten consumption. Below are COVID news and research updates that specifically relate to Celiac Disease.

Autoimmunity & COVID: Are You More at Risk?

Researchers in Italy studied whether autoimmunity increased the risk of SARS-CoV-2 infection in patients not taking immunosuppressive drugs. Researchers contacted 400 patients with the following autoimmune diseases: autoimmune gastritis, celiac disease, autoimmune thyroid disease (both Graves’ disease and Hashimoto’s thyroiditis), and Type 1 diabetes. Positive COVID-19 test results were reported in 33 patients. Only 3 of the 33 patients required hospitalization, while 8 were asymptomatic, and 22 had mild symptoms. No deaths were recorded.

Read More »

Covid-19 Outcomes in Autoimmune Disease Patients

Autoimmune disease is currently considered a risk factor for severe COVID-19. A research article published in Rheumatology last Fall summarized 30-day outcomes of autoimmune disease (AD) patients following hospitalization with COVID-19. AD patients diagnosed and/or hospitalized between January and June 2020 with COVID-19 were included, and their 30 day outcomes were compared to patients with at least one AD hospitalized with influenza from September 2017 through April 2018.

Read More »

Treating MIS-C with Phase 3 Celiac Drug

Even after a COVID-19 infection has passed, SARS-CoV-2 particles may linger in the gut and make their way into the bloodstream. This often triggers a cytokine storm and hyper-inflammatory response (MIS-C) within multiple areas of the body. These include the heart, lungs, kidneys, brain, and GI organs. 

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.